OraPharma
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, OraPharma sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
OraPharma: 5 sponsored US clinical trials, none currently recruiting.
OraPharma sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 5 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Periodontitis, with 1 trials.
Upper-quartile sponsor footprint
OraPharma sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Arestin - Use in Subjects With Peri-Implantitis (With Subgingival Microbiological Evaluation)
NCT01517334
Arestin - Use in Subjects With Peri-Implantitis
NCT01539564
Antibiotic Study for Dental Implants
NCT00662532
Long-term Safety of Minocycline in Patients With Gum Disease
NCT00668746
Effect of Adjunctive Treatment With Arestin on the Subgingival Microflora in Patients With Moderate to Advanced Periodontitis
NCT00371332
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 4 |
| Phase 4 | 1 |
Therapeutic Areas
How the OraPharma archive is shaped
5 indexed studies, none listed as recruiting (0% open); 5 completed (100%).
Phase mix: 5 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Periodontitis (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
OraPharma: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
OraPharma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this OraPharma page
5 registered trials is a research-attention snapshot, not an endorsement of OraPharma or any single study.
- None of OraPharma's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Periodontitis is the condition OraPharma studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Periodontitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
OraPharma pipeline card: 5 registered trials from official public datasets.Report a data error.